An Outbreak of Beta-2 Adrenergic Toxicity from Adulterated Heroin - 25/07/16
Doi : 10.1016/j.amjmed.2016.03.027
Moiez Ali, BS a, Yevgeniya Foster, MD b, Megan Brooks, MD, MPH c, Pahresah Roomiany, MD, MS c, ⁎ 
a Duke University School of Medicine, Durham, NC
b Department of Internal Medicine Residency Program, Duke University, Durham, NC
c Department of Hospital Medicine, Duke University, Duke Regional Hospital, Durham, NC
∗Requests for reprints should be addressed to Pahresah Roomiany, MD, MS, Duke University, Department of Hospital Medicine, Duke Regional Hospital, 3643 North Roxboro Road, Durham, NC 27704.Duke UniversityDepartment of Hospital MedicineDuke Regional Hospital3643 North Roxboro RoadDurhamNC27704
Plan
| Funding: None. |
|
| Conflict of Interest: None of the authors report any conflict of interest or disclosures. |
|
| Authorship: All authors had access to the data and participated in this case report. |
© 2016
Elsevier Inc. Tous droits réservés.
Vol 129 - N° 8
P. e125-e126 - août 2016 Retour au numéro
Article précédent
- Prognostic Importance of Sex-Specific Cardiac Troponin T 99th Percentiles in Suspected Acute Coronary Syndrome
- Kai M. Eggers, Tomas Jernberg, Bertil Lindahl
- Chronic Acetaminophen Use Associated with Anion-Gap Metabolic Acidosis
- Hassan Kamran, Nalini Ram
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?